Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

U.S. Navy approves phase I trial of Multikine in patients with HIV/HPV and perianal warts

Feb. 4, 2014

Burnet Institute receives grant to evaluate HIV test

Feb. 4, 2014

Merck & Co. discloses novel agents for HIV infection

Jan. 31, 2014

Researchers at ViiV Healthcare disclose novel agents for HIV infection

Jan. 30, 2014

Dolutegravir approved in Europe for the treatment of HIV

Jan. 22, 2014

GeoVax discloses preliminary topline results from phase I trial of vaccine to control HIV infections

Jan. 15, 2014

FDA approves Isentress pediatric oral suspension

Jan. 10, 2014

FDA approves phase IIb study of PRO-140 for HIV-1

Jan. 9, 2014

Immune Response BioPharma announces development of a novel HIV/AIDS vaccine

Dec. 30, 2013

FDA approves Complera for patients with HIV switching from a stable regimen

Dec. 16, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...